About This Calculator

This Heparin Infusion Calculator (Weight-based) calculator is a clinical support tool designed for educational purposes. It helps estimate the initial loading dose (bolus) and continuous infusion rate for unfractionated heparin (UFH) based on patient weight and specific clinical indications. It also provides guidance for dose adjustments using a standard aPTT-based nomogram.

Disclaimer: This tool is not a substitute for professional clinical judgment. All calculations must be verified by a qualified healthcare provider. Always adhere to your institution’s specific protocols and guidelines for heparin administration and monitoring.

Outputs Explained

The calculator provides the following key outputs for heparin dosing:

• Bolus Dose (units): The total number of heparin units to be administered as an initial intravenous push to rapidly achieve a therapeutic level.
• Bolus Volume (mL): The volume of the heparin solution required to deliver the calculated bolus dose, based on the specified concentration.
• Initial Infusion Rate (units/hr): The initial rate of the continuous infusion in heparin units per hour.
• Initial Infusion Rate (mL/hr): The pump rate for the continuous infusion in milliliters per hour, calculated from the units/hr rate and solution concentration.
• Dose Adjustment Recommendations: For subsequent dosing, the tool provides specific actions based on the patient’s aPTT result, such as re-bolusing, changing the infusion rate, or temporarily stopping the infusion.

How to Use the Tool

Follow these steps to determine the appropriate heparin dosing schedule:

For Initial Dosing:

1. Enter Patient Weight: Input the patient’s weight and select the unit (kg or lbs). The tool will convert lbs to kg for calculations.
2. Select Heparin Concentration: Choose from standard premixed bag concentrations (e.g., 25,000 units in 250 mL) or select “Custom Concentration” to enter the specific total units and volume of your solution.
3. Choose Clinical Protocol: Select the relevant indication, such as VTE (Venous Thromboembolism), ACS (Acute Coronary Syndrome), or Ischemic Stroke. Each protocol uses a different weight-based dosing and has different maximum dose caps.
4. Calculate: Press the “Calculate Initial Dose” button to see the results.

For Dose Adjustments:

1. Enter Current aPTT: Input the patient’s most recent activated partial thromboplastin time (aPTT) value in seconds.
2. Enter Current Infusion Rate: Input the current rate at which the pump is running in mL/hr.
3. Verify Initial Inputs: Ensure the patient weight and heparin concentration are still correctly entered in the top section of the calculator.
4. Calculate: Press “Calculate Adjustment” to receive the recommended action based on the aPTT nomogram.

Dosing Overview

Weight-based unfractionated heparin (UFH) dosing is the standard of care for achieving rapid and reliable anticoagulation. The strategy involves an initial bolus dose to quickly raise plasma heparin levels to the therapeutic range, followed by a continuous infusion to maintain that level.

• Venous Thromboembolism (VTE): Generally requires a higher intensity protocol with an 80 units/kg bolus and an initial infusion of 18 units/kg/hr.
• Acute Coronary Syndrome (ACS): Typically uses a less intense protocol, starting with a 60 units/kg bolus and a 12 units/kg/hr infusion, often in conjunction with antiplatelet agents. Maximum doses are lower to balance efficacy with bleeding risk.
• Ischemic Stroke: Often initiated without a bolus to minimize the risk of hemorrhagic conversion, starting directly with a maintenance infusion (e.g., 12 units/kg/hr).

Dosing is titrated according to aPTT results, with a typical therapeutic goal of 46-70 seconds (approximately 1.5-2.5 times the control value), though this can vary by institution.

Switching Anticoagulants

Transitioning from a heparin infusion to another anticoagulant (e.g., Low Molecular Weight Heparin like enoxaparin, or a Direct Oral Anticoagulant like apixaban or rivaroxaban) requires careful timing to maintain therapeutic anticoagulation while minimizing bleeding risk.

• To LMWH or Fondaparinux: The heparin infusion is typically stopped, and the first dose of the new injectable anticoagulant can be given immediately.
• To a DOAC (e.g., apixaban, rivaroxaban): The heparin infusion is stopped, and the first dose of the DOAC can be administered immediately or within 2 hours.
• To Warfarin: Warfarin therapy is often initiated concurrently with the heparin infusion. Heparin is continued for a minimum of 5 days and until the INR is therapeutic (typically ≥2.0) for at least 24 hours, at which point the infusion can be stopped.

These are general guidelines; always consult institutional protocols for specific instructions on switching.

Infusion Interruption

Because heparin has a very short half-life (around 60-90 minutes), even brief interruptions in the infusion can lead to a subtherapeutic state. If the infusion must be stopped for a procedure or other reason, a clear plan for re-initiation is essential.

For interruptions lasting longer than a brief period, the prescriber should be consulted. Depending on the duration and clinical context, re-bolusing may be necessary upon restarting the infusion to quickly restore therapeutic levels.

Safety Alerts

Unfractionated heparin is a high-risk medication requiring diligent monitoring.

• Bleeding Risk: The most common and serious side effect is bleeding. Patients should be monitored for signs of bleeding (e.g., hematuria, melena, hematemesis, severe bruising).
• Heparin-Induced Thrombocytopenia (HIT): A rare but severe immune-mediated complication characterized by a significant drop in platelet count (typically >50% from baseline) occurring 5-10 days after starting heparin. Platelet counts must be monitored regularly.
• Monitoring: Regular monitoring of aPTT (typically every 6 hours until stable, then daily) and platelet counts is mandatory.

Frequently Asked Questions (FAQ)

Why is patient weight required for the calculation?

Heparin dosing is standardized based on patient weight (units per kilogram) to ensure the dose is tailored to the individual’s size and volume of distribution, leading to more predictable therapeutic levels.

What is the difference between the VTE and ACS protocols?

The VTE protocol is more aggressive, with a higher bolus (80 u/kg) and infusion rate (18 u/kg/hr), to quickly treat an existing clot. The ACS protocol is less intense (60 u/kg bolus, 12 u/kg/hr infusion) as it’s typically used to prevent clot formation in coronary arteries, often alongside other antiplatelet drugs, requiring a balance to minimize bleeding risk.

Why does the Ischemic Stroke protocol have a zero bolus?

In acute ischemic stroke, giving a large initial bolus of heparin increases the risk of hemorrhagic transformation (bleeding into the damaged brain tissue). Therefore, treatment is often started with only a maintenance infusion to provide anticoagulation more gently.

What if my hospital’s heparin concentration is not listed?

Select the “Custom Concentration” option from the dropdown menu. This will reveal fields where you can enter the exact total units of heparin and the total volume (in mL) of the IV bag you are using.

What do the “bolus cap” and “infusion cap” mean?

These are maximum safety limits. For very heavy patients, the calculated weight-based dose could become excessively high. The caps prevent dangerously large doses by setting an absolute maximum for the bolus (e.g., 4000 units for ACS) and the infusion rate (e.g., 1000 units/hr for ACS), regardless of the patient’s weight.

What is aPTT and why is it used for dose adjustments?

aPTT (activated Partial Thromboplastin Time) is a blood test that measures the time it takes for a clot to form. It reflects the activity of the intrinsic coagulation pathway, which is inhibited by heparin. It is used to monitor heparin’s effect and ensure the dose is therapeutic—not too high (risk of bleeding) or too low (risk of clotting).

What does the tool recommend if the aPTT is very high?

Based on the standard nomogram, if the aPTT is significantly elevated (e.g., >90 seconds), the calculator will recommend stopping the infusion for 60 minutes, then restarting it at a lower rate. This allows the heparin level to decrease safely before resuming therapy.

Can I use this calculator for low-molecular-weight heparin (LMWH)?

No. This calculator is designed exclusively for intravenous unfractionated heparin (UFH). LMWH (e.g., enoxaparin, dalteparin) has different dosing, pharmacokinetics, and monitoring requirements.

References

1. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608. doi:10.1016/j.chest.2021.07.055
2. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139-e228. doi:10.1016/j.jacc.2014.09.017
3. U.S. Food and Drug Administration. Heparin Sodium Injection – Prescribing Information. Drugs@FDA Database. Accessed October 2023. Link to FDA Database
4. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med. 1993;119(9):874-881. doi:10.7326/0003-4819-119-9-199311010-00002